Researchers are amassing more clues about COVID-19 symptoms:

The dominant origin story of Alzheimer’s focuses on the build-up of amyloid protein “clumps” on the brain.  

In a major win for Alzheimer’s research, an inexpensive blood test appears to identify the disease just as well as pricier and more invasive methods—and it could be available in 2–3 years, the 

People are understandably be devastated to learn they carry the gene variant known as APOE e4, which greatly increases their chances of getting Alzheimer’s disease. But there’s good news for some: Another gene may protect against its devastating effects.

For decades, a woman in Medellín, Colombia sidestepped the dementia that was an early death sentence for generations of her family, The New York Times 

Alzheimer’s slow onset makes the devastating disease hard to track until it’s too late—but a spate of studies suggest diabetes and high blood sugar levels hint at a source.

A study of Colombia’s largest family with inherited early-onset Alzheimer’s may lead to important advances in prevention. Supported by the NIH, the first-of-its-kind study will test the drug crenezumab on family members who are high risk but currently healthy.  

New evidence of a possible link between exposure to air pollution and risk of Alzheimer’s disease and other forms of dementia is provided by a University of Southern California study to be published in Transitional Psychiatry next week. The study reports that levels of air…

Could Alzheimer’s be caused by an infection? Boston researcher Robert Moir is investigating the controversial idea. In a series of studies, he and his colleagues have detailed how the protein that builds up on Alzheimer’s patients’ brains also protects mouse brains against…

Microscopic networks of neural cells known as “minibrains” can teach researchers about diseases ranging from Alzheimer’s to Zika. The minibrains, which mimic the embryonic human brain, have allowed researchers Thomas Hartung, of the Johns Hopkins Bloomberg School of Public…